Prof Jakob Passweg is chair of hematology at the Basel University Hospital. He is particularly interested in studying outcome of patients receiving hematopoetic stem cell transplantation and in improving results of hematopoetic stem cell transplantation through immune intervention such as adoptive transfer of immune reactive cells. He has served in the past on the board of the European Group of Blood and Marrow Transplantation, is Co-Editor of the journal BMT and is currently President of the Swiss Cancer League.

Selected original publications
 

• Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, Kühne T, Favre G. and Gratwohl A. (2004). Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia 18:1835-1838.

• Cesaro S, Marsh J, Tridello G, Rovò A, Maury S, Montante B, Masszi T, Van Lint MT, Afanasyev B, Iriondo Atienza A, Bierings M, Carbone C, Doubek M, Lanino E, Sarhan M, Risitano A, Steinerova K, Wahlin A, Pegoraro A. and Passweg JR. (2010). Retrospective Survey on the Prevalence and Outcome of Prior Autoimmune Diseases in Patients with Aplastic Anemia Reported to the Registry of the European Group for Blood and Marrow Transplantation. Acta Haematol. 124:19-22.

• Passweg JR, Giagounidis AA, Simcock M, Aul C, Dobbelstein C, Stadler M, Ossenkoppele G, Hofmann WK, Schilling K, Tichelli A. and Ganser A. (2010) Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care--SAKK 33/99. J Clin Oncol. 29:303-309.

• Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A. and Eapen M. (2011). Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.Biol Blood Marrow Transplant. 17:1869-73.

• Tichelli A, Schrezenmeier H, Socié G, Marsh J, Bacigalupo A, Dührsen U, Franzke A, Hallek M, Thiel E, Wilhelm M, Höchsmann B, Barrois A, Champion K. and Passweg JR. (2011). A randomized controlled study in newly-diagnosed severe aplastic anemia patients receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the EBMT. Blood 117:4434-41.

• Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, Witte TD, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A. and Madrigal A; for the European Group for Blood and Marrow Transplantation (EBMT). (2012). The EBMT activity survey: 1990-2010. Bone Marrow Transplant. in press.

Reviews

• Passweg JR. and Marsh JC. (2010). Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. Am Soc Hematol Educ Program 2010:36-42.